Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK8245 in Type 2 Diabetes
NCT00846391Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Dec 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mk-8245 in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Dec 2008; status: terminated.
02
Drugs
mk-8245
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00846391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00846391.